ES2026146T3 - Procedimiento para la preparacion de un medio de incubacion para ensayos inmunometricos en fase solida. - Google Patents

Procedimiento para la preparacion de un medio de incubacion para ensayos inmunometricos en fase solida.

Info

Publication number
ES2026146T3
ES2026146T3 ES198787105621T ES87105621T ES2026146T3 ES 2026146 T3 ES2026146 T3 ES 2026146T3 ES 198787105621 T ES198787105621 T ES 198787105621T ES 87105621 T ES87105621 T ES 87105621T ES 2026146 T3 ES2026146 T3 ES 2026146T3
Authority
ES
Spain
Prior art keywords
procedure
preparation
solid phase
incubation media
immunometric tests
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787105621T
Other languages
English (en)
Inventor
Hans-Detlef Dr. Dopatka
Rudolf Schmidtberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of ES2026146T3 publication Critical patent/ES2026146T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBEN MEDIOS DE INCUBACION PARA TEST DE FASE FIJA INMUNOMETRICOS, QUE CONTIENEN LASTOFERRIN. ESTOS MEDIOS DE INCUBACION TIENEN LA VENTAJE FRENTE A LOS MEDIOS APLICADOS HASTA AHORA, QUE SOBRE TODO, TAMBIEN EN CASO DE LA APLICACION DE MATERIALES DE PRUEBA CALIENTES EVITAN EN LOS TEST LOS RESULTADOS ADULTERADOS EN LA IDENTIFICACION DE ANTIGENOS O ANTICUERPOS.
ES198787105621T 1986-11-13 1987-04-15 Procedimiento para la preparacion de un medio de incubacion para ensayos inmunometricos en fase solida. Expired - Lifetime ES2026146T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863638767 DE3638767A1 (de) 1986-11-13 1986-11-13 Laktoferrin enthaltendes inkubationsmedium fuer festphasenimmunometrisches verfahren und seine verwendung

Publications (1)

Publication Number Publication Date
ES2026146T3 true ES2026146T3 (es) 1992-04-16

Family

ID=6313865

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787105621T Expired - Lifetime ES2026146T3 (es) 1986-11-13 1987-04-15 Procedimiento para la preparacion de un medio de incubacion para ensayos inmunometricos en fase solida.

Country Status (5)

Country Link
US (1) US4988629A (es)
EP (1) EP0270729B1 (es)
AT (2) ATE68886T1 (es)
DE (2) DE3638767A1 (es)
ES (1) ES2026146T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0219766A (ja) * 1988-07-08 1990-01-23 Teijin Ltd 免疫測定方法及びそれに用いる試薬キット
DE3901458A1 (de) * 1989-01-19 1990-07-26 Behringwerke Ag Verwendung von zwei- oder dreiwertigen kationen in immunchemischen tests
DE4037764A1 (de) 1990-11-28 1992-06-04 Behringwerke Ag Waschloesung fuer festphasen-immunometrische verfahren, die stabilisatoren fuer das markierungssystem enthaelt und ihre verwendung
US8592219B2 (en) * 2005-01-17 2013-11-26 Gyros Patent Ab Protecting agent
US20090010819A1 (en) * 2004-01-17 2009-01-08 Gyros Patent Ab Versatile flow path
US20080233594A1 (en) * 2005-01-17 2008-09-25 Gyros Patent Ab Method For Detecting An At Least Bivalent Analyte Using Two Affinity Reactants
EP1848996A4 (en) * 2005-01-17 2009-12-02 Gyros Patent Ab METHOD FOR THE COMMON TRANSPORT OF A REACTANTS WITH AN AMPHIPHILIC MACROMOLECULAR FABRIC IN A MICROFLUID TRANSPORT CHANNEL

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572220A (en) * 1976-10-07 1980-07-30 Mochida Pharm Co Ltd Immunochemical process of measuring physiologically active substances
US4184849A (en) * 1977-12-05 1980-01-22 Technicon Instruments Corporation Mixed agglutination
GB2013688B (en) * 1978-01-26 1982-06-30 Technicon Instr Insolubilised proteins and immunoassays utilising them
GB2013211B (en) * 1978-01-26 1982-06-30 Technicon Instr Immunoassays using f(ab')2 fragments
CA1160566A (en) * 1980-04-25 1984-01-17 Harald Gallati Immunological determination method
FR2505615A1 (fr) * 1981-05-15 1982-11-19 Elf Aquitaine Procede d'extraction de lactoferrine et d'immunoglobulines du lait
JPS61145200A (ja) * 1984-12-19 1986-07-02 Snow Brand Milk Prod Co Ltd ウシラクトフェリンの分離精製法
US4784941A (en) * 1985-04-08 1988-11-15 Genetic Systems Corporation Expression and diagnostic use of pENV-3 encoded peptides which are immunologically reactive with antibodies to LAV
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease

Also Published As

Publication number Publication date
EP0270729B1 (de) 1991-10-23
ATA261687A (de) 1993-09-15
AT397580B (de) 1994-05-25
DE3774086D1 (de) 1991-11-28
US4988629A (en) 1991-01-29
ATE68886T1 (de) 1991-11-15
DE3638767A1 (de) 1988-05-26
EP0270729A1 (de) 1988-06-15

Similar Documents

Publication Publication Date Title
PT89889A (pt) Processo para a preparacao de testes imunologicos contendo derivados de igg polimericos para a compensacao de factores perturbantes
SE8102558L (sv) Immunologisk bestemmningsmetod
ATE14630T1 (de) Creatinin-antikoerper.
ES2009939A6 (es) Un inmunoensayo para la deteccion simultanea de antigenos yno anticuerpos en una muestra a ensayar de un fluido fisiologico.
ES2067480T3 (es) Metodo de inmunoensayo para la deteccion de antigenos.
ES511797A0 (es) "metodo para ensayar reacciones antigeno-anticuerpo".
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
ATE51449T1 (de) Immunchemisches messverfahren fuer haptene und proteine.
DK0378175T3 (da) Diagnostisk påvisning under anvendelse af kimære antistoffer
ES2070488T3 (es) Procedimiento para la deteccion de enfermedades malignas.
ES2026146T3 (es) Procedimiento para la preparacion de un medio de incubacion para ensayos inmunometricos en fase solida.
DE59207717D1 (de) Verfahren zur Bestimmung einer immunologisch bindefähigen Substanz
PT81050B (pt) Anticorpo monoclonal anti-urocinase e processo para a preparacao de composicoes de materia de teste biologicos que o utilizam
ES2036189T3 (es) Un metodo para efectuar un inmunoensayo de diagnostico.
ES546338A0 (es) Procedimiento para la determinacion de una sustancia capaz de fijarse inmunologicamente
DE3781808D1 (de) Diagnosetestverfahren fuer schweinedysenterie.
ES8405155A1 (es) Procedimiento de inmunoanalisis para determinar etosuximida en una muestra de analisis.
ES2029890T3 (es) Inmunoensayo.
ES8608321A1 (es) Hibridomas productores de anticuerpos monoclonales especifi-cos para la inmunoglobulina e (ige)humana del mieloma ns
DK633589A (da) Immunoafproevning til samtidig paavisning af antigen og/eller antistof samt proevesaet til dens gennemfoerelse
IL71508A0 (en) Specific binding assay method and test kit for the determination of haptens,antigens and antibodies

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 270729

Country of ref document: ES